# TriSalus Life Sciences, Inc.: filings

TLSI · Nasdaq · CIK 1826667 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/tlsi.md) · [Financials](/companies/tlsi/financials.md) · [Filings](/companies/tlsi/filings.md) · [Insiders](/companies/tlsi/insiders.md)

## Reports and events: 142 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 126, 8-K 87, 3 34, 425 28, 424B3 23, 10-Q 17, CORRESP 17, EFFECT 17, UPLOAD 15, SC 13G 14, S-4/A 8, SC 13G/A 7, 10-K 6, DEF 14A 6, POS AM 6, S-3 5, SC 13D 5, SCHEDULE 13D/A 5, SCHEDULE 13G 5, DEFA14A 4, S-1 4, S-1/A 4, S-8 4, SC 13D/A 4, 10-K/A 3, 424B5 3, ARS 3, D 3, S-4 3, SCHEDULE 13G/A 3, SC TO-I/A 3, 5 2, NT 10-K 2, PRE 14A 2, SC TO-I 2, SEC STAFF LETTER 2, 10-Q/A 1, 144 1, 25-NSE 1, 3/A 1, 424B4 1, 8-A12B 1, CERT 1, DEFM14A 1, DRS 1, NT 10-Q 1, S-1MEF 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-22 | 20:14 ET | [8-K](/filings/0001628280-26-063031.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-063031 |
| 2026-08-06 | 20:04 ET | [10-Q](/filings/0001628280-26-054275.md) | Quarterly report, period 2026-06-30 | 0001628280-26-054275 |
| 2026-08-06 | 20:01 ET | [8-K](/filings/0001628280-26-054264.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-054264 |
| 2026-05-14 | 20:03 ET | [8-K](/filings/0001628280-26-035068.md) | 5.07 Shareholder vote results | 0001628280-26-035068 |
| 2026-05-12 | 20:08 ET | [10-Q](/filings/0001628280-26-034100.md) | Quarterly report, period 2026-03-31 | 0001628280-26-034100 |
| 2026-05-12 | 20:03 ET | [8-K](/filings/0001628280-26-034082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-034082 |
| 2026-04-29 | 20:32 ET | [8-K](/filings/0001628280-26-028425.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-028425 |
| 2026-04-07 | 13:10 ET | [8-K](/filings/0001628280-26-023991.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-023991 |
| 2026-03-31 | 22:17 ET | [DEF 14A](/filings/0001628280-26-022124.md) | Proxy statement, period 2025-12-31 | 0001628280-26-022124 |
| 2026-03-05 | 21:08 ET | [10-K](/filings/0001628280-26-015163.md) | Annual report, period 2025-12-31 | 0001628280-26-015163 |
| 2026-03-05 | 21:03 ET | [8-K](/filings/0001628280-26-015155.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-015155 |
| 2026-02-20 | 21:15 ET | [8-K](/filings/0001493152-26-007598.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-007598 |
| 2026-02-09 | 13:59 ET | [8-K](/filings/0001628280-26-006219.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-006219 |
| 2026-01-12 | 12:09 ET | [8-K](/filings/0001628280-26-001743.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-001743 |
| 2025-11-13 | 21:14 ET | [10-Q](/filings/0001628280-25-052043.md) | Quarterly report, period 2025-09-30 | 0001628280-25-052043 |
| 2025-11-13 | 21:08 ET | [8-K](/filings/0001628280-25-052008.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-052008 |
| 2025-10-01 | 20:28 ET | [8-K](/filings/0001628280-25-043440.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-043440 |
| 2025-08-29 | 20:15 ET | [8-K](/filings/0001826667-25-000129.md) | 5.02 Departure or appointment of officers or directors | 0001826667-25-000129 |
| 2025-08-12 | 20:11 ET | [10-Q](/filings/0001826667-25-000117.md) | Quarterly report, period 2025-06-30 | 0001826667-25-000117 |
| 2025-08-12 | 20:03 ET | [8-K](/filings/0001826667-25-000115.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000115 |
| 2025-08-04 | 11:33 ET | [SCHEDULE 13D/A](/filings/0001826667-25-000108.md) | Ownership report, active investor, amended | 0001826667-25-000108 |
| 2025-08-01 | 21:16 ET | [SCHEDULE 13D/A](/filings/0001826667-25-000106.md) | Ownership report, active investor, amended | 0001826667-25-000106 |
| 2025-07-24 | 21:30 ET | [8-K](/filings/0001826667-25-000103.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001826667-25-000103 |
| 2025-06-23 | 21:29 ET | [8-K](/filings/0001826667-25-000077.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001826667-25-000077 |
| 2025-06-16 | 21:07 ET | [8-K](/filings/0001826667-25-000074.md) | 5.07 Shareholder vote results | 0001826667-25-000074 |
| 2025-05-30 | 20:03 ET | [8-K](/filings/0001826667-25-000071.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001826667-25-000071 |
| 2025-05-30 | 20:00 ET | [10-K/A](/filings/0001826667-25-000070.md) | Annual report, amended, period 2024-12-31 | 0001826667-25-000070 |
| 2025-05-15 | 11:54 ET | [10-Q](/filings/0001826667-25-000051.md) | Quarterly report, period 2025-03-31 | 0001826667-25-000051 |
| 2025-05-15 | 11:34 ET | [8-K](/filings/0001826667-25-000049.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000049 |
| 2025-05-02 | 20:17 ET | [SCHEDULE 13D/A](/filings/0001415889-25-011783.md) | Ownership report, active investor, amended | 0001415889-25-011783 |
| 2025-04-30 | 21:21 ET | [DEF 14A](/filings/0001826667-25-000040.md) | Proxy statement, period 2025-06-12 | 0001826667-25-000040 |
| 2025-04-30 | 12:05 ET | [8-K](/filings/0001104659-25-041862.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-041862 |
| 2025-04-23 | 12:57 ET | [8-K](/filings/0001826667-25-000036.md) | 5.02 Departure or appointment of officers or directors | 0001826667-25-000036 |
| 2025-04-17 | 20:31 ET | [8-K](/filings/0001826667-25-000033.md) | 5.02 Departure or appointment of officers or directors | 0001826667-25-000033 |
| 2025-04-15 | 21:04 ET | [10-K](/filings/0001826667-25-000030.md) | Annual report, period 2024-12-31 | 0001826667-25-000030 |
| 2025-03-27 | 11:56 ET | [8-K](/filings/0001826667-25-000024.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000024 |
| 2025-02-25 | 21:24 ET | [8-K](/filings/0001826667-25-000021.md) | 5.02 Departure or appointment of officers or directors | 0001826667-25-000021 |
| 2025-02-19 | 22:31 ET | [8-K](/filings/0001826667-25-000018.md) | 2.03 New direct financial obligation; 3.02 Unregistered sale of equity | 0001826667-25-000018 |
| 2025-02-03 | 16:08 ET | [8-K](/filings/0001826667-25-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000014 |
| 2025-01-31 | 21:27 ET | [8-K](/filings/0001826667-25-000011.md) | 5.02 Departure or appointment of officers or directors | 0001826667-25-000011 |
| 2025-01-23 | 13:16 ET | [8-K](/filings/0001826667-25-000007.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001826667-25-000007 |
| 2025-01-08 | 21:05 ET | [8-K](/filings/0001104659-25-002023.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-002023 |
| 2024-12-19 | 21:12 ET | [SCHEDULE 13D/A](/filings/0001415889-24-029847.md) | Ownership report, active investor, amended | 0001415889-24-029847 |
| 2024-12-19 | 21:12 ET | [SCHEDULE 13D/A](/filings/0001415889-24-029845.md) | Ownership report, active investor, amended | 0001415889-24-029845 |
| 2024-11-14 | 13:34 ET | [10-Q](/filings/0001826667-24-000051.md) | Quarterly report, period 2024-09-30 | 0001826667-24-000051 |
| 2024-11-14 | 13:02 ET | [8-K](/filings/0001104659-24-118338.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-118338 |
| 2024-11-01 | 20:07 ET | [8-K](/filings/0001104659-24-113486.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-113486 |
| 2024-08-15 | 12:55 ET | [8-K](/filings/0001104659-24-089936.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-089936 |
| 2024-08-14 | 20:05 ET | [10-Q](/filings/0001826667-24-000039.md) | Quarterly report, period 2024-06-30 | 0001826667-24-000039 |
| 2024-07-19 | 20:48 ET | [DEF 14A](/filings/0001826667-24-000034.md) | Proxy statement, period 2024-07-10 | 0001826667-24-000034 |

Page 1 of 3. [Older](/companies/tlsi/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.